Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Herlev Hospital
Hackensack Meridian Health
GlaxoSmithKline
Providence Health & Services
Hoosier Cancer Research Network
University of Pittsburgh
Georgetown University
Dana-Farber Cancer Institute
Takeda
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Clinigen, Inc.
RAPT Therapeutics, Inc.
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Lumos Pharma
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Baptist Health South Florida
Bristol-Myers Squibb
Idera Pharmaceuticals, Inc.
Regeneron Pharmaceuticals
Abramson Cancer Center at Penn Medicine
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Duke University
Incyte Corporation
University of California, San Francisco
University of Louisville
University of Michigan Rogel Cancer Center
Vanderbilt-Ingram Cancer Center
Bristol-Myers Squibb
M.D. Anderson Cancer Center
AbbVie
Northwestern University
University of Virginia
University of Washington
NYU Langone Health
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb